Fund moves

West Pharmaceutical Services (WST)Conestoga Capital Advisors, LLC reduced its stake -20K shares

Conestoga Capital Advisors, LLC reduced its stake in West Pharmaceutical Services, per its Q2 2026 13F.

111K
Shares reported · -20K vs prior quarter
0.87%
Disclosed portfolio weight
$40M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on Form 8-K announcing that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board”) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been hired in order to ensure a smooth transition.”
  2. Jul 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  3. Jul 23, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.0%
  2. Sep 8, 2026Insider · 1 personInsiders: 3 sales (~$2.8M)
  3. Sep 11, 2026InsiderOfficer sold ~$863K of WST shares in the open market
  4. Sep 14, 2026InsiderOfficer sold ~$888K of WST shares in the open market
  5. Sep 15, 2026InsiderOfficer sold ~$921K of WST shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for West Pharmaceutical Services

For West Pharmaceutical Services, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 20 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WST page.

How this filing works

Other disclosures at West Pharmaceutical Services

Everything OQRO holds on this company is on its WST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data